Process View
Any process that modulates the frequency, rate or extent of introducing a phosphate group to a tyrosine residue of a Stat1 protein.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of tyrosine phosphorylation of stat1 protein"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| EGFR | epidermal growth factor receptor | 0.986 | ||
| GHR | growth hormone receptor | 0.973 | ||
| JAK2 | Janus kinase 2 | 0.965 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.915 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.873 | Human | |
| FGF1 | fibroblast growth factor 1 (acidic) | 0.753 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.750 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.739 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.710 | ||
| VEGFA | vascular endothelial growth factor A | 0.692 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.691 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.674 | Human | |
| LAT | linker for activation of T cells | 0.610 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.479 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.407 | ||
| INSR | insulin receptor | 0.336 | ||
| NRP1 | neuropilin 1 | 0.290 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.265 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.249 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.247 | ||
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.240 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.215 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.190 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.185 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.169 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.142 | Human | |
| STAT5A | signal transducer and activator of transcription 5A | 0.138 | ||
| IL23A | interleukin 23, alpha subunit p19 | 0.136 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.121 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.116 | Human | |
| FGFR2 | fibroblast growth factor receptor 2 | 0.113 | Human | |
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.109 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.108 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.108 | Human | |
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.093 | ||
| IRS1 | insulin receptor substrate 1 | 0.081 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.079 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.079 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.070 | ||
| JAK1 | Janus kinase 1 | 0.063 | ||
| TNF | tumor necrosis factor | 0.057 | ||
| EPOR | erythropoietin receptor | 0.055 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.050 | ||
| STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.049 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.048 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.047 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.045 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.044 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.043 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.041 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.040 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.040 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.037 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.032 | ||
| FGF10 | fibroblast growth factor 10 | 0.032 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.032 | Human | |
| STAT4 | signal transducer and activator of transcription 4 | 0.029 | ||
| PGF | placental growth factor | 0.028 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.027 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.027 | ||
| CD33 | CD33 molecule | 0.027 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.026 | Human | |
| TRAF3 | TNF receptor-associated factor 3 | 0.024 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.024 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.021 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.020 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.020 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.019 | ||
| COMMD1 | copper metabolism (Murr1) domain containing 1 | 0.019 | ||
| LIFR | leukemia inhibitory factor receptor alpha | 0.018 | Human | |
| IL6R | interleukin 6 receptor | 0.018 | ||
| PTEN | phosphatase and tensin homolog | 0.018 | ||
| SLA | Src-like-adaptor | 0.017 | ||
| FGF7 | fibroblast growth factor 7 | 0.016 | ||
| PDGFC | platelet derived growth factor C | 0.015 | ||
| SOCS2 | suppressor of cytokine signaling 2 | 0.015 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.015 | ||
| IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.015 | ||
| KITLG | KIT ligand | 0.015 | ||
| TLR3 | toll-like receptor 3 | 0.014 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.014 | ||
| IL4R | interleukin 4 receptor | 0.014 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.013 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.013 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.013 | ||
| PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.013 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.012 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.012 | ||
| OSMR | oncostatin M receptor | 0.012 | Human | |
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.012 | ||
| SYK | spleen tyrosine kinase | 0.012 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.011 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.011 | ||
| CD14 | CD14 molecule | 0.011 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.011 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.011 | Human | |
| SOCS1 | suppressor of cytokine signaling 1 | 0.010 | Mouse | |
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.010 | ||
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.010 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.010 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.010 |